Jens Juul Holst

Jens Juul Holst

Professor

ORCID: 0000-0001-6853-3805

Publication year:
All
21 - 30 out of 63Page size: 10
Sort by: 1st author
  1. Published

    A single supplement of a standardised bilberry (Vaccinium myrtillus L.) extract (36 % wet weight anthocyanins) modifies glycaemic response in individuals with type 2 diabetes controlled by diet and lifestyle

    Hoggard, N., Cruickshank, M., Moar, K., Bestwick, C., Holst, Jens Juul, Russell, W. & Horgan, G., 2013, In: Journal of Nutritional Science. 2, 9 p., e22.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Acute differential effects of dietary protein quality on postprandial lipemia in obese non-diabetic subjects

    Holmer-Jensen, J., Mortensen, L. S., Astrup, A., de Vrese, M., Holst, Jens Juul, Thomsen, C. & Hermansen, K., 2013, In: Nutrition Research. 33, 1, p. 34-40 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Glucagon-like peptides 1 and 2, enteroglucagon, glicentin and oxyntomodulin

    Holst, Jens Juul, Deacon, Carolyn F., Hartmann, Bolette & Pedersen, Jens, 2013, Handbook of Biologically Active Peptides . Kastin, AJ. (ed.). 2 ed. Elsevier, p. 1241-1250 10 p.

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Education

  4. Published

    Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings

    Holst, Jens Juul & Vilsbøll, Tina, 2013, In: Diabetes, Obesity and Metabolism. 15, 1, p. 3-14 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Incretin hormones and the satiation signal

    Holst, Jens Juul, Sep 2013, In: International journal of obesity (2005). 37, 9, p. 1161-8 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery

    Holst, Jens Juul, Dec 2013, In: Current Opinion in Pharmacology. 13, 6, p. 983-8 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Pancreatic safety of GLP-1-based therapeutic agents: further insights from rodent studies?

    Holst, Jens Juul, Sep 2013, In: Diabetologia. 56, 9, p. 1869-72 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Is there a place for incretin therapies in obesity and prediabetes?

    Holst, Jens Juul & Deacon, Carolyn F., 13 Feb 2013, In: Trends in Endocrinology and Metabolism. 24, 3, p. 145-152 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study

    Idorn, T., Knop, Filip Krag, Jørgensen, M., Jensen, T., Resuli, M., Hansen, P. M., Christensen, Karl Bang, Holst, Jens Juul, Hornum, Mads & Feldt-Rasmussen, Bo, 26 Apr 2013, In: B M J Open. 3, 4, p. 1-10 11 p., e002764.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease

    Idorn, T., Knop, Filip Krag, Jørgensen, M., Holst, Jens Juul, Hornum, Mads & Feldt-Rasmussen, Bo, May 2013, In: Kidney International. 83, 5, p. 915-23 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 Next

ID: 4207